Indeed, MMP9 is distinctly increased in serum, and especially in the synovial fluid of RA patients, partially through conferring synovial fibroblast with survival benefits, thereby inducing inflammation and degradation of the cartilage (Xue et al., 2014). Here, MMP9 is linked to rheumatoid arthritis.